An OMV-Based Nanovaccine as Antigen Presentation Signal Enhancer for Cancer Immunotherapy.
Lu Y, Ma N, Cheng K, Liu G, Liang J, Xu C, Li D, Cao C, Gao X, Chen L, Wang X, Wang Y, Zhao X, Jiang K.
Lu Y, et al. Among authors: zhao x.
Adv Mater. 2025 Jan 15:e2413392. doi: 10.1002/adma.202413392. Online ahead of print.
Adv Mater. 2025.
PMID: 39811977